NCT04405973View on ClinicalTrials.gov

Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO

CompletedOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

May 19, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
COVID-19SARS-CoV 2Extracorporeal Membrane OxygenationARDS
Interventions
DEVICE

vv-ECMO

vv-ECMO required in severe COVID-19 ARDS

Trial Locations (1)

79106

University Clinic Freiburg, Freiburg im Breisgau

All Listed Sponsors
lead

Dr. Alexander Supady

OTHER

NCT04405973 - Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO | Biotech Hunter | Biotech Hunter